YORK: Aptamer Group plc (AIM: APTA), a developer of next-generation synthetic binders for the life science industry, announced Tuesday a new development and licensing agreement with an established global life sciences and diagnostics company, part of a major multinational conglomerate….
LONDON: Aptamer Group plc (AIM: APTA), the developer of novel Optimer® binders to enable innovation in the life sciences industry, announced a partnership with Microsaic Systems plc to develop a panel of Optimer binders for integration into a water testing…
LONDON: Aptamer Group plc (AIM: APTA), a developer of novel Optimer® binders for the life sciences industry, has entered into an agreement with Timser Group, a pharmaceutical company specializing in women’s health. The deal, valued at up to £465,000, aims…
LONDON, UK: Aptamer Group plc (AIM: APTA) has released its unaudited interim financial results for the six months ending December 31, 2023. Despite a challenging economic climate, the company has shown resilience with a revenue of £0.3 million and a…
LONDON: Aptamer Group plc, a company that develops novel Optimer binders for the life sciences industry, has signed a deal with a biotech firm that makes genetic medicines. The deal involves using Aptamer Group’s platform to discover Optimers that can…